gené

Robotics & AI

Discover Medicines With the Power of AI: Profluent, Fueled by Salesforce Research and Endorsed by Jeff Dean

Last year, Salesforce, the company best known for its cloud sales support software (and Slack), spearheaded a project called ProGen to design proteins using generative AI. “Many drugs — enzymes and antibodies, for example — consist of proteins,” Madani said. Fed into a generative AI model, data about proteins can be used to predict entirely new proteins with novel functions. Other companies and research groups have demonstrated viable ways in which generative AI can be used to predict proteins. And DeepMind, Google’s AI research lab, has a system called AlphaFold that predicts complete protein structures, achieving speed and accuracy far surpassing older, less complex algorithmic methods.

Max Chen
March 25, 2024
1 Comment

Venture

Strategizing Venture Capital’s Resilience during a Three-Year Liquidity Decline

Hello, and welcome back to Equity, the podcast about the business of startups, where we unpack the numbers and nuance behind the headlines. This is our interview show, where we sit down with interesting, knowledgeable folks and dive deep into their favorite topics. For this weekend’s Special Equity Edition, we invited Gené Teare to come back on the podcast. Longtime listeners will recall that we’ve had Gené on a time or two to chat venture capital data with us, and she’s back to do the same this week! Yep, we’re back to dig into Q4 2023 venture capital results and what’s coming up this year.